141 related articles for article (PubMed ID: 2519612)
21. Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase.
Okayasu T; Hoshii K; Seyama K; Ishibashi T; Imai Y
Biochim Biophys Acta; 1986 Mar; 876(1):58-64. PubMed ID: 3947669
[TBL] [Abstract][Full Text] [Related]
22. A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor.
Blank ML; Cress EA; Snyder F
Biochem Biophys Res Commun; 1984 Jan; 118(1):344-50. PubMed ID: 6696762
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
Chepenik KP; Wykle RL
Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622
[TBL] [Abstract][Full Text] [Related]
24. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
Hwang SB; Lee CS; Cheah MJ; Shen TY
Biochemistry; 1983 Sep; 22(20):4756-63. PubMed ID: 6313047
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and proaggregatory activity of 1-O-(2-methyloctadecyl)-2-O-acetyl-rac-glycero-3-phosphocholine.
Schmid B; Ostermann G; Kertscher HP
Chem Phys Lipids; 1991 Nov; 60(1):77-82. PubMed ID: 1813180
[TBL] [Abstract][Full Text] [Related]
26. Conversion of alkylacetylglycerol to platelet-activating factor in HL-60 cells and subcellular localization of the mediator.
Vallari DS; Record M; Snyder F
Arch Biochem Biophys; 1990 Feb; 276(2):538-45. PubMed ID: 2154953
[TBL] [Abstract][Full Text] [Related]
27. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
28. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
[TBL] [Abstract][Full Text] [Related]
29. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
30. Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture.
Bussolino F; Breviario F; Aglietta M; Sanavio F; Bosia A; Dejana E
Biochim Biophys Acta; 1987 Jan; 927(1):43-54. PubMed ID: 3024738
[TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor stimulates prostaglandin synthesis in cultured cells.
Kawaguchi H; Yasuda H
Hypertension; 1986 Mar; 8(3):192-7. PubMed ID: 3081442
[TBL] [Abstract][Full Text] [Related]
32. Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction.
Russo S; Bussolati B; Deambrosis I; Mariano F; Camussi G
J Immunol; 2003 Nov; 171(10):5489-97. PubMed ID: 14607955
[TBL] [Abstract][Full Text] [Related]
33. Studies on ether-phospholipids of vascular smooth muscle cells. Identification of a rapid Ca(2+)-dependent hydrolysis of alkyl-phosphatidylethanolamine promoted by endothelin-l.
Comminges C; Georgeaud V; Maury E; Cariven C; Prévost MC; Chap H
Biochim Biophys Acta; 1997 Jan; 1355(1):69-80. PubMed ID: 9030203
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell.
Triggiani M; Hubbard WC; Chilton FH
J Immunol; 1990 Jun; 144(12):4773-80. PubMed ID: 2141044
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position.
Karasawa K; Satoh N; Masuda M; Setaka M; Hashimoto K; Ishibashi K; Nojima S
J Biochem; 1991 Nov; 110(5):683-7. PubMed ID: 1723729
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of the effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet activating factor on histamine and leukotriene C4 release from human leukocytes.
Columbo M; Horowitz EM; Patella V; Kagey-Sobotka A; Chilton FH; Lichtenstein LM
J Allergy Clin Immunol; 1993 Aug; 92(2):325-33. PubMed ID: 7688778
[TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro.
Camoratto AM; Grandison L
Endocrinology; 1989 Mar; 124(3):1502-6. PubMed ID: 2917522
[TBL] [Abstract][Full Text] [Related]
38. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
39. Vitamin E enhances the acylation of 1-O-alkyl-sn-glycero-3-phosphocholine in human endothelial cells.
Tran K; D'Angelo AF; Choy PC; Chan AC
Biochem J; 1994 Feb; 298 ( Pt 1)(Pt 1):115-9. PubMed ID: 8129709
[TBL] [Abstract][Full Text] [Related]
40. Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells.
Gaumond F; Fortin D; Stankova J; Rola-Pleszczynski M
J Cardiovasc Pharmacol; 1997 Aug; 30(2):169-75. PubMed ID: 9269943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
